Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomedical Research | 14 | 2025 | 467 | 4.290 |
Why?
|
| Trust | 8 | 2024 | 157 | 3.070 |
Why?
|
| Community-Institutional Relations | 8 | 2021 | 208 | 2.620 |
Why?
|
| Community-Based Participatory Research | 8 | 2023 | 336 | 2.600 |
Why?
|
| Clinical Trials as Topic | 10 | 2023 | 249 | 2.140 |
Why?
|
| Minority Groups | 7 | 2022 | 663 | 2.120 |
Why?
|
| Research Subjects | 4 | 2020 | 34 | 1.980 |
Why?
|
| Research Personnel | 5 | 2022 | 191 | 1.890 |
Why?
|
| Humans | 93 | 2025 | 42163 | 1.860 |
Why?
|
| Interprofessional Relations | 3 | 2020 | 56 | 1.740 |
Why?
|
| Research Design | 10 | 2023 | 370 | 1.610 |
Why?
|
| Alzheimer Disease | 9 | 2025 | 972 | 1.410 |
Why?
|
| Patient Selection | 7 | 2025 | 192 | 1.410 |
Why?
|
| Papillomavirus Infections | 4 | 2023 | 363 | 1.360 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 73 | 1.300 |
Why?
|
| Health Status Disparities | 3 | 2020 | 705 | 1.260 |
Why?
|
| United States | 25 | 2025 | 5072 | 1.200 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 73 | 1.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2022 | 959 | 1.080 |
Why?
|
| Independent Living | 2 | 2017 | 47 | 1.060 |
Why?
|
| Middle Aged | 30 | 2024 | 11819 | 1.050 |
Why?
|
| Female | 44 | 2025 | 24018 | 1.050 |
Why?
|
| Aged | 31 | 2025 | 7982 | 1.020 |
Why?
|
| Osteoporosis | 4 | 2009 | 48 | 0.990 |
Why?
|
| Male | 39 | 2025 | 22779 | 0.970 |
Why?
|
| Cognition Disorders | 8 | 2012 | 243 | 0.940 |
Why?
|
| Papillomavirus Vaccines | 3 | 2023 | 168 | 0.930 |
Why?
|
| Communication | 4 | 2023 | 207 | 0.920 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 573 | 0.890 |
Why?
|
| Certification | 1 | 2024 | 21 | 0.880 |
Why?
|
| Genetic Counseling | 1 | 2024 | 13 | 0.870 |
Why?
|
| Qualitative Research | 8 | 2024 | 526 | 0.870 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 61 | 0.870 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 250 | 0.860 |
Why?
|
| Lung Diseases | 1 | 2024 | 62 | 0.810 |
Why?
|
| Cardiovascular System | 1 | 2023 | 37 | 0.800 |
Why?
|
| Attitude of Health Personnel | 4 | 2021 | 222 | 0.790 |
Why?
|
| Community Health Services | 3 | 2022 | 207 | 0.780 |
Why?
|
| Access to Information | 2 | 2020 | 14 | 0.770 |
Why?
|
| Dementia | 4 | 2025 | 155 | 0.770 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 309 | 0.760 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 164 | 0.750 |
Why?
|
| Neoplasms | 3 | 2022 | 1341 | 0.740 |
Why?
|
| Comparative Effectiveness Research | 2 | 2018 | 15 | 0.740 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 30 | 0.740 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 175 | 0.740 |
Why?
|
| Pilot Projects | 5 | 2022 | 733 | 0.720 |
Why?
|
| Tennessee | 4 | 2024 | 88 | 0.700 |
Why?
|
| Parents | 3 | 2023 | 359 | 0.700 |
Why?
|
| Financing, Government | 1 | 2021 | 20 | 0.700 |
Why?
|
| Cognition | 3 | 2017 | 458 | 0.700 |
Why?
|
| Adult | 18 | 2024 | 13458 | 0.700 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 188 | 0.690 |
Why?
|
| Disability Evaluation | 2 | 2013 | 74 | 0.690 |
Why?
|
| Mammography | 3 | 2019 | 211 | 0.690 |
Why?
|
| Epidemiologic Research Design | 1 | 2020 | 18 | 0.680 |
Why?
|
| Socioeconomic Factors | 3 | 2023 | 1221 | 0.680 |
Why?
|
| Education, Professional | 1 | 2020 | 9 | 0.670 |
Why?
|
| Education, Distance | 1 | 2021 | 46 | 0.660 |
Why?
|
| Universities | 2 | 2021 | 539 | 0.660 |
Why?
|
| Problem-Based Learning | 1 | 2020 | 41 | 0.660 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 3077 | 0.640 |
Why?
|
| Focus Groups | 8 | 2024 | 398 | 0.630 |
Why?
|
| Needs Assessment | 2 | 2018 | 180 | 0.630 |
Why?
|
| Schools, Medical | 1 | 2021 | 208 | 0.620 |
Why?
|
| Vitamin D Deficiency | 4 | 2009 | 107 | 0.620 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 81 | 0.620 |
Why?
|
| Schizophrenia | 1 | 2020 | 91 | 0.610 |
Why?
|
| Organizational Culture | 1 | 2018 | 15 | 0.590 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 53 | 0.590 |
Why?
|
| Phenotype | 2 | 2023 | 774 | 0.590 |
Why?
|
| Managed Care Programs | 1 | 2018 | 39 | 0.580 |
Why?
|
| Group Processes | 2 | 2019 | 23 | 0.580 |
Why?
|
| Executive Function | 3 | 2017 | 55 | 0.570 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 532 | 0.570 |
Why?
|
| Social Perception | 1 | 2018 | 71 | 0.560 |
Why?
|
| Aged, 80 and over | 12 | 2025 | 2803 | 0.550 |
Why?
|
| Education, Medical | 1 | 2019 | 117 | 0.550 |
Why?
|
| Geriatric Assessment | 4 | 2013 | 65 | 0.550 |
Why?
|
| Health Services Research | 1 | 2018 | 161 | 0.550 |
Why?
|
| Health Education | 2 | 2020 | 358 | 0.550 |
Why?
|
| Patient Participation | 1 | 2018 | 87 | 0.540 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 136 | 0.540 |
Why?
|
| Health Occupations | 1 | 2017 | 17 | 0.540 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 146 | 0.540 |
Why?
|
| Health Literacy | 2 | 2019 | 120 | 0.540 |
Why?
|
| Interinstitutional Relations | 1 | 2017 | 51 | 0.530 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 1679 | 0.530 |
Why?
|
| Hypertension | 1 | 2024 | 823 | 0.520 |
Why?
|
| Cultural Competency | 2 | 2018 | 137 | 0.520 |
Why?
|
| Medically Underserved Area | 1 | 2017 | 118 | 0.510 |
Why?
|
| Physicians | 1 | 2018 | 180 | 0.500 |
Why?
|
| Awards and Prizes | 3 | 2023 | 28 | 0.490 |
Why?
|
| Asthma | 1 | 2020 | 410 | 0.490 |
Why?
|
| Health Personnel | 4 | 2022 | 262 | 0.480 |
Why?
|
| Medication Therapy Management | 1 | 2015 | 9 | 0.470 |
Why?
|
| Pharmaceutical Services | 2 | 2015 | 23 | 0.470 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 40 | 0.460 |
Why?
|
| Capacity Building | 1 | 2015 | 99 | 0.430 |
Why?
|
| Obesity | 2 | 2024 | 1131 | 0.430 |
Why?
|
| Incidence | 4 | 2020 | 1054 | 0.410 |
Why?
|
| Program Evaluation | 1 | 2015 | 358 | 0.410 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 106 | 0.410 |
Why?
|
| Patient Preference | 2 | 2024 | 55 | 0.410 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 181 | 0.400 |
Why?
|
| Young Adult | 7 | 2024 | 4936 | 0.380 |
Why?
|
| Mass Screening | 3 | 2021 | 531 | 0.380 |
Why?
|
| Adolescent | 6 | 2024 | 5950 | 0.380 |
Why?
|
| Information Dissemination | 3 | 2024 | 66 | 0.370 |
Why?
|
| Risk Factors | 7 | 2020 | 3942 | 0.340 |
Why?
|
| Age of Onset | 3 | 2012 | 115 | 0.340 |
Why?
|
| Neuropsychological Tests | 6 | 2013 | 281 | 0.340 |
Why?
|
| Bone Density Conservation Agents | 2 | 2007 | 27 | 0.320 |
Why?
|
| Bone Density | 4 | 2017 | 102 | 0.320 |
Why?
|
| Genomics | 2 | 2022 | 289 | 0.310 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 1058 | 0.310 |
Why?
|
| Decision Making | 2 | 2024 | 242 | 0.300 |
Why?
|
| Educational Status | 2 | 2020 | 335 | 0.280 |
Why?
|
| Positron-Emission Tomography | 2 | 2025 | 93 | 0.280 |
Why?
|
| Interviews as Topic | 2 | 2019 | 428 | 0.270 |
Why?
|
| Retrospective Studies | 5 | 2022 | 2485 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 744 | 0.260 |
Why?
|
| Fractures, Bone | 1 | 2007 | 61 | 0.250 |
Why?
|
| Mood Disorders | 1 | 2006 | 54 | 0.250 |
Why?
|
| Psychometrics | 3 | 2018 | 350 | 0.250 |
Why?
|
| Fractures, Spontaneous | 1 | 2005 | 6 | 0.240 |
Why?
|
| Depression | 2 | 2012 | 837 | 0.240 |
Why?
|
| Vitamin D | 4 | 2009 | 196 | 0.230 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 680 | 0.220 |
Why?
|
| Amyloid | 1 | 2025 | 66 | 0.220 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1266 | 0.220 |
Why?
|
| Depressive Disorder, Major | 3 | 2012 | 128 | 0.220 |
Why?
|
| Densitometry | 1 | 2004 | 14 | 0.220 |
Why?
|
| Demography | 2 | 2020 | 195 | 0.220 |
Why?
|
| Poverty | 1 | 2007 | 395 | 0.210 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 428 | 0.210 |
Why?
|
| Mediastinum | 1 | 2023 | 6 | 0.210 |
Why?
|
| Cerebrovascular Disorders | 3 | 2010 | 43 | 0.210 |
Why?
|
| Sertraline | 3 | 2012 | 7 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 94 | 0.200 |
Why?
|
| Missouri | 2 | 2017 | 7 | 0.200 |
Why?
|
| Antidepressive Agents | 3 | 2012 | 61 | 0.190 |
Why?
|
| Buprenorphine | 1 | 2023 | 51 | 0.190 |
Why?
|
| Students, Medical | 1 | 2024 | 153 | 0.190 |
Why?
|
| Parent-Child Relations | 1 | 2023 | 125 | 0.190 |
Why?
|
| Censuses | 1 | 2022 | 28 | 0.190 |
Why?
|
| Curriculum | 1 | 2024 | 311 | 0.180 |
Why?
|
| Heart | 1 | 2023 | 181 | 0.180 |
Why?
|
| Aspirin | 1 | 2022 | 88 | 0.180 |
Why?
|
| Age Factors | 2 | 2019 | 1139 | 0.180 |
Why?
|
| Connecticut | 1 | 2021 | 11 | 0.180 |
Why?
|
| South Carolina | 1 | 2021 | 25 | 0.180 |
Why?
|
| Brain | 4 | 2025 | 1452 | 0.170 |
Why?
|
| Papillomaviridae | 1 | 2022 | 136 | 0.170 |
Why?
|
| North Carolina | 1 | 2021 | 122 | 0.170 |
Why?
|
| Adrenergic Agonists | 1 | 2020 | 2 | 0.170 |
Why?
|
| Veterans | 1 | 2023 | 203 | 0.170 |
Why?
|
| Patient Care | 1 | 2020 | 31 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2020 | 1586 | 0.170 |
Why?
|
| Chronic Disease | 1 | 2024 | 541 | 0.170 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 92 | 0.160 |
Why?
|
| Schizophrenic Psychology | 1 | 2020 | 16 | 0.160 |
Why?
|
| Social Justice | 1 | 2020 | 64 | 0.160 |
Why?
|
| Motivation | 2 | 2021 | 492 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 233 | 0.160 |
Why?
|
| Communication Barriers | 1 | 2020 | 60 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 188 | 0.160 |
Why?
|
| Social Welfare | 1 | 2019 | 29 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 32 | 0.150 |
Why?
|
| Health Resources | 1 | 2019 | 37 | 0.150 |
Why?
|
| Research | 1 | 2020 | 177 | 0.150 |
Why?
|
| Mortality | 1 | 2020 | 174 | 0.150 |
Why?
|
| Social Responsibility | 1 | 2018 | 16 | 0.150 |
Why?
|
| Faculty, Medical | 1 | 2019 | 74 | 0.150 |
Why?
|
| Patient Advocacy | 1 | 2018 | 22 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 479 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 187 | 0.150 |
Why?
|
| Southeastern United States | 1 | 2018 | 58 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 163 | 0.140 |
Why?
|
| Quality of Life | 1 | 2023 | 599 | 0.140 |
Why?
|
| Trail Making Test | 1 | 2017 | 3 | 0.140 |
Why?
|
| Culture | 1 | 2019 | 172 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2019 | 158 | 0.140 |
Why?
|
| Health Promotion | 1 | 2024 | 691 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 577 | 0.140 |
Why?
|
| Logistic Models | 1 | 2020 | 1001 | 0.130 |
Why?
|
| Socialization | 1 | 2017 | 20 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2020 | 336 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 234 | 0.130 |
Why?
|
| Child | 2 | 2023 | 3381 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 216 | 0.130 |
Why?
|
| Health Surveys | 1 | 2018 | 401 | 0.130 |
Why?
|
| Comorbidity | 3 | 2009 | 725 | 0.130 |
Why?
|
| Parathyroid Hormone | 2 | 2007 | 40 | 0.130 |
Why?
|
| Diphosphonates | 2 | 2007 | 18 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2018 | 170 | 0.120 |
Why?
|
| Affect | 1 | 2017 | 177 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 118 | 0.120 |
Why?
|
| Pharmacists | 2 | 2015 | 56 | 0.120 |
Why?
|
| Public Opinion | 1 | 2015 | 20 | 0.120 |
Why?
|
| Creatinine | 1 | 2015 | 102 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2015 | 238 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2021 | 583 | 0.110 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 512 | 0.110 |
Why?
|
| Program Development | 1 | 2015 | 237 | 0.110 |
Why?
|
| Health Status | 1 | 2017 | 432 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2017 | 916 | 0.100 |
Why?
|
| Lipids | 1 | 2015 | 256 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2015 | 177 | 0.100 |
Why?
|
| Personality Inventory | 1 | 2012 | 82 | 0.100 |
Why?
|
| Leadership | 1 | 2013 | 84 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2012 | 33 | 0.090 |
Why?
|
| Mental Status Schedule | 2 | 2012 | 18 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 438 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1020 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2015 | 662 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 303 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 236 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 358 | 0.080 |
Why?
|
| Psychology | 1 | 2009 | 39 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 47 | 0.080 |
Why?
|
| Femur | 1 | 2009 | 46 | 0.070 |
Why?
|
| Probability | 1 | 2009 | 82 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 44 | 0.070 |
Why?
|
| ROC Curve | 1 | 2009 | 157 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2009 | 93 | 0.070 |
Why?
|
| Time Factors | 1 | 2013 | 1848 | 0.070 |
Why?
|
| Nutritional Status | 1 | 2009 | 115 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1051 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2007 | 62 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2007 | 57 | 0.070 |
Why?
|
| Calcitonin | 1 | 2007 | 5 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2007 | 23 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 42 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2006 | 37 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2007 | 31 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 1729 | 0.060 |
Why?
|
| Hippocampus | 2 | 2012 | 591 | 0.060 |
Why?
|
| Institutionalization | 1 | 2005 | 2 | 0.060 |
Why?
|
| Lewy Bodies | 1 | 2006 | 29 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2005 | 4 | 0.060 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2006 | 17 | 0.060 |
Why?
|
| Social Environment | 1 | 2007 | 218 | 0.060 |
Why?
|
| Weight Loss | 1 | 2006 | 138 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 113 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2005 | 31 | 0.060 |
Why?
|
| Hip Fractures | 1 | 2005 | 29 | 0.060 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2025 | 1 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2005 | 83 | 0.060 |
Why?
|
| Ketanserin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2025 | 49 | 0.060 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2004 | 15 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2007 | 362 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2005 | 225 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 438 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2007 | 845 | 0.050 |
Why?
|
| Age Distribution | 1 | 2004 | 249 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 508 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2004 | 185 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 487 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 246 | 0.050 |
Why?
|
| Medicare | 1 | 2025 | 326 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 210 | 0.050 |
Why?
|
| Ecosystem | 1 | 2023 | 171 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2022 | 89 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 28 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2022 | 99 | 0.040 |
Why?
|
| Linear Models | 2 | 2015 | 311 | 0.040 |
Why?
|
| Prevalence | 1 | 2005 | 1597 | 0.040 |
Why?
|
| Publications | 1 | 2020 | 10 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 245 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 332 | 0.040 |
Why?
|
| Latin America | 1 | 2020 | 53 | 0.040 |
Why?
|
| Neural Pathways | 2 | 2012 | 139 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2019 | 128 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 708 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2017 | 2 | 0.030 |
Why?
|
| Telephone | 1 | 2017 | 35 | 0.030 |
Why?
|
| Urination Disorders | 1 | 2017 | 4 | 0.030 |
Why?
|
| Religion | 1 | 2018 | 90 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 1574 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 25 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2008 | 132 | 0.030 |
Why?
|
| Emotions | 1 | 2018 | 251 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 431 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 305 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 487 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 1019 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 1 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 22 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 58 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 57 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 167 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 151 | 0.020 |
Why?
|
| Amygdala | 1 | 2012 | 125 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 175 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 280 | 0.020 |
Why?
|
| Physical Examination | 1 | 2006 | 45 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 2004 | 12 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 428 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1076 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 764 | 0.010 |
Why?
|
| Pharmacies | 1 | 1954 | 23 | 0.010 |
Why?
|
| Pharmacy | 1 | 1954 | 34 | 0.010 |
Why?
|